TSP
CDMO

Tappan Street Partners’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Tappan Street Partners’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$9.02M Buy
2,871,000
+1,214,781
+73% +$4.56M 25.25% 1
2017
Q2 		$7.05M Buy
1,656,219
+741,933
+81% +$3.04M 20.61% 1
2017
Q1 		$4.19M Buy
+914,286
New +$3.06M 10.49% 4

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Tappan Street Partners's CDMO Position: Q3 2017 in Review

Tappan Street Partners increased its Avid Bioservices, Inc. Common Stock (CDMO) stake by 73% in Q3 2017, buying an estimated $4.56M and bringing the position to 2,871,000 shares worth $9.02M. The position accounts for 25.25% of the portfolio, ranked #1.

Tappan Street Partners first reported a position in CDMO in Q1 2017 and has held it in 3 quarters since. 53 funds tracked by Wall St. Rank hold CDMO as of Q3 2017.

  • Tappan Street Partners held 2,871,000 shares of Avid Bioservices, Inc. Common Stock worth $9.02M as of Q3 2017.
  • Tappan Street Partners bought 1,214,781 Avid Bioservices, Inc. Common Stock shares in Q3 2017, an estimated $4.56M.
  • Avid Bioservices, Inc. Common Stock made up 25.25% of Tappan Street Partners's portfolio in Q3 2017, its #1 holding.
  • Tappan Street Partners first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2017 and has held it in 3 quarters since.
  • 53 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2017.

Based on Tappan Street Partners's 13F filing for Q3 2017, filed 14 Nov 2017.